Europe’s Corporate Stress Test: 1 in 6 Firms Under Transformation Pressure, 6% at Risk of Restructuring
BCG’s Transform and Special Situations Index Analyzes 1,700 Public European Companies, Identifying the Share Showing Signs of Operational Challenges and Financial Instability Companies Facing Transformation or Restructuring Pressure Represent 3.5 Million Jobs and More Than $300 Billion in GDP, With Germany Most Exposed Consumer & Retail, Automotive, Chemicals, and Transportation & Logistics Are Most At-Risk […]
WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities
SHANGHAI, July 7, 2025 /PRNewswire/ — WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently provided updates to investors on the status of its A-share repurchase and H-share acquisition activities in Q2 2025. […]
TrinaTracker Receives the first Wind Tunnel Test Technical Review Report in China by DNV
SHANGHAI, July 7, 2025 /PRNewswire/ — TrinaTracker, the smart solar tracking system provider under Trinasolar (SHA: 688599), announced that it has received a third party technical review of the wind tunnel test program for its Vanguard 1P tracker, with a report issued by the independent energy expert and assurance provider, DNV. The test program, conducted by […]
Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2] STOBOCLO and OSENVELT, among the first wave of biosimilars referencing PROLIA and XGEVA respectively, are commercially available in the U.S. Celltrion further expands its portfolio, delivering cost-effective and high-quality biologic medicines to wider range of patients […]
RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
NEW YORK, July 7, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. So what: If you purchased Rocket […]
Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Snapdragon X Elite
TAIPEI, July 7, 2025 /PRNewswire/ — Advantech is proud to introduce its latest suite of high-performance edge AI compute solutions powered by the Snapdragon® X Elite platform – the AOM-6731, AIMB-293, and SOM-6820. Built on this groundbreaking platform, these innovative products are engineered to meet the demanding requirements of modern industrial applications by delivering exceptional processing power, integrated […]
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 7, 2025 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the Investigational New Drug (IND) application for SCG101V, marking the first-ever investigational cell therapy to enter regulatory […]
SRPT Investors Have Opportunity to Lead Sarepta Therapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, July 7, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline. So What: If you purchased […]
Fosun International’s FTSE Russell ESG Rating Outperforms Global Industry Average, Marks Fourth Consecutive Year in FTSE4Good Index
HONG KONG, July 7, 2025 /PRNewswire/ — On 8 July 2025, the world’s leading index company, FTSE Russell, recently announced the latest Environmental, Social and Governance (ESG) rating results for Fosun International Limited (HKEX stock code: 00656) (“Fosun International”). In 2025, Fosun International’s FTSE Russell ESG rating was upgraded to 3.9, consistently outperforming the global industry average […]
IOVA Deadline: IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, July 7, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class Period”), of the important July 14, 2025 lead plaintiff deadline. So What: If you purchased Iovance securities […]